VRDN icon

Viridian Therapeutics
VRDN

Overview Fund Activity

26 hedge funds and large institutions have $109M invested in Viridian Therapeutics in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 11 closing their positions.

Holders
26
Holders Change
-7
Holders Change %
-21.21%
% of All Funds
0.45%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
4
Increased
10
Reduced
4
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PA
1
Perceptive Advisors
New York
$14.5M
2
D.E. Shaw & Co
2
D.E. Shaw & Co
New York
$13.2M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$6.48M
4
ABG
4
Ally Bridge Group
New York
$15.7M
5
Millennium Management
5
Millennium Management
New York
$2.15M

Top Sellers

1
LGM
1
Logos Global Management
California
$0
2
CAM
2
Cormorant Asset Management
Massachusetts
$6.27M
3
BI
3
BVF Inc
California
$6.4M
4
SCM
4
Soleus Capital Management
Connecticut
$0
5
DCM
5
Driehaus Capital Management
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Citadel Advisors
26
Citadel Advisors
Florida
– -$44K -485,995 Closed
SCM
27
Soleus Capital Management
Connecticut
– -$1.13M -67,685 Closed
DCM
28
Driehaus Capital Management
Illinois
– -$557K -33,333 Closed
MS
29
Maven Securities
Jersey
– -$470K -27,898 Closed
Renaissance Technologies
30
Renaissance Technologies
New York
– -$221K -13,240 Closed
Squarepoint
31
Squarepoint
New York
– -$195K -11,668 Closed
Osaic Holdings
32
Osaic Holdings
Arizona
– -$16K -950 Closed
TRCT
33
Tower Research Capital (TRC)
New York
– -$2K -118 Closed
1
2